These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15078592)

  • 41. Bovine coronavirus infection in Ontario 1990-1991.
    Carman PS; Hazlett MJ
    Can Vet J; 1992 Dec; 33(12):812-4. PubMed ID: 17424135
    [No Abstract]   [Full Text] [Related]  

  • 42. Thromboinflammation in coronavirus disease 2019: The clot thickens.
    Iffah R; Gavins FNE
    Br J Pharmacol; 2022 May; 179(10):2100-2107. PubMed ID: 34128218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiovascular Impacts on COVID-19 Infected Patients.
    Raghavan S; Gayathri R; Kancharla S; Kolli P; Ranjitha J; Shankar V
    Front Cardiovasc Med; 2021; 8():670659. PubMed ID: 34055939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice.
    Crisan Dabija R; Antohe I; Trofor A; Antoniu SA
    Expert Rev Anti Infect Ther; 2021 Dec; 19(12):1553-1562. PubMed ID: 34015985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2).
    Sessa F; Salerno M; Pomara C
    Medicina (Kaunas); 2021 Mar; 57(4):. PubMed ID: 33806100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunosuppressive Drugs and COVID-19: A Review.
    Schoot TS; Kerckhoffs APM; Hilbrands LB; van Marum RJ
    Front Pharmacol; 2020; 11():1333. PubMed ID: 32982743
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries.
    Elshabrawy HA
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32585913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome.
    Hendren NS; Drazner MH; Bozkurt B; Cooper LT
    Circulation; 2020 Jun; 141(23):1903-1914. PubMed ID: 32297796
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).
    Tong TR
    Perspect Med Virol; 2006; 16():43-95. PubMed ID: 32287586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis.
    Venkataraman T; Frieman MB
    Antiviral Res; 2017 Jul; 143():142-150. PubMed ID: 28390872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies.
    Geller C; Varbanov M; Duval RE
    Viruses; 2012 Nov; 4(11):3044-68. PubMed ID: 23202515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a molecular-beacon-based multi-allelic real-time RT-PCR assay for the detection of human coronavirus causing severe acute respiratory syndrome (SARS-CoV): a general methodology for detecting rapidly mutating viruses.
    Hadjinicolaou AV; Farcas GA; Demetriou VL; Mazzulli T; Poutanen SM; Willey BM; Low DE; Butany J; Asa SL; Kain KC; Kostrikis LG
    Arch Virol; 2011 Apr; 156(4):671-80. PubMed ID: 21221674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice.
    Zhao J; Zhao J; Perlman S
    J Virol; 2010 Sep; 84(18):9318-25. PubMed ID: 20610717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice.
    Zhao J; Zhao J; Van Rooijen N; Perlman S
    PLoS Pathog; 2009 Oct; 5(10):e1000636. PubMed ID: 19851468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS.
    Oudit GY; Kassiri Z; Jiang C; Liu PP; Poutanen SM; Penninger JM; Butany J
    Eur J Clin Invest; 2009 Jul; 39(7):618-25. PubMed ID: 19453650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interferon and cytokine responses to SARS-coronavirus infection.
    Thiel V; Weber F
    Cytokine Growth Factor Rev; 2008 Apr; 19(2):121-32. PubMed ID: 18321765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues.
    Tang JW; To KF; Lo AW; Sung JJ; Ng HK; Chan PK
    J Med Virol; 2007 Sep; 79(9):1245-53. PubMed ID: 17607787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms.
    Chen WJ; Yang JY; Lin JH; Fann CS; Osyetrov V; King CC; Chen YM; Chang HL; Kuo HW; Liao F; Ho MS
    Clin Infect Dis; 2006 Jun; 42(11):1561-9. PubMed ID: 16652313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
    Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW
    Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.